Octapharma Limited
3
contracts
0
councils
£1,670,258,640
awarded
includes framework ceilings
2
shared awards
won alongside another supplier
Contracts
most recently awarded first| Awarded | Contract | Buyer | Value | Status |
| 1 Jan 2025 | Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) | Norfolk and Norwich University Hospitals NHS Foundation Trust | £71,550 | active |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin | NHS England | £905,187,090 | active |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 | NHS England | £765,000,000 | active |